Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lilly, K. J
Right arrow Articles by Rizzo, R. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lilly, K. J
Right arrow Articles by Rizzo, R. J
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Early results of a comprehensive operative and perfusion strategy to attenuate the incidence of adverse neurological outcomes in on-pump coronary artery bypass grafting (CABG) patients

Kevin J Lilly

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA, klilly{at}capecodhealth.org

Jorge M Balaguer

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Paul A Pirundini

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Michaela A Smith

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Gilbert Connelly

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Lorrie Jeanne Campbell

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Pauline C Philie

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Michael McAdams

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

William Riley

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Rene Dekkers

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Daniel Fitzgerald

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Lawrence H Cohn

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Robert J Rizzo

Division of Cardiac Surgery, Brigham & Women’s Hospital/Cape Cod Hospital, Harvard Medical School, Boston, MA, USA

Adverse neurological events, both focal (Type I) and non-focal (Type II), have been appreciated in postoperative on-pump coronary artery bypass grafting (CABG) patients for many years. Advanced age is a significant risk factor for adverse neurological events following CABG surgery. With full knowledge that our elderly population of patients was at high risk for these untoward neurological events, we adopted a comprehensive operative and perfusion strategy in an attempt to attenuate the incidence of these complications. Our strategy included efforts to minimise the number of emboli generated during the operation, avoid cerebral hypoperfusion, and attenuate the systemic inflammatory response. From 15 August 2002 to 31 December 2005, we performed 355 on-pump CABG operations. The incidence of Type I focal injury was 0/355 (0%), the incidence of Type II non-focal injury was 9/355 (2.5%), and postoperative mortality was 2/355 (0.6%). These results compared favorably to the results predicted by the Society of Thoracic Surgeons’ (STS) model, and may suggest efficacy.

Perfusion, Vol. 21, No. 6, 311-317 (2006)
DOI: 10.1177/0267659106073986


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?